PortfoliosLab logo
Invesco Dynamic Biotechnology & Genome ETF (PBE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US73935X8561

CUSIP

46137V787

Issuer

Invesco

Inception Date

Jun 23, 2005

Region

North America (U.S.)

Leveraged

1x

Index Tracked

Dynamic Biotech & Genome Intellidex Index (AMEX)

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

PBE has an expense ratio of 0.59%, placing it in the medium range.


Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Invesco Dynamic Biotechnology & Genome ETF (PBE) returned -6.29% year-to-date (YTD) and -4.10% over the past 12 months. Over the past 10 years, PBE returned 1.05% annually, underperforming the S&P 500 benchmark at 10.89%.


PBE

YTD

-6.29%

1M

5.54%

6M

-5.65%

1Y

-4.10%

5Y*

1.79%

10Y*

1.05%

^GSPC (Benchmark)

YTD

1.30%

1M

12.79%

6M

1.49%

1Y

12.35%

5Y*

15.12%

10Y*

10.89%

*Annualized

Monthly Returns

The table below presents the monthly returns of PBE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.26%-3.82%-4.86%-1.83%0.05%-6.29%
2024-2.32%1.95%-1.25%-5.94%3.98%2.42%8.26%2.43%-2.85%-2.32%3.37%-5.63%1.10%
20235.17%-4.73%-1.34%-0.28%-3.67%1.66%3.53%-2.98%-7.35%-6.04%9.34%12.36%3.71%
2022-14.72%-0.76%2.92%-9.33%1.26%1.39%5.68%-0.89%-2.55%7.62%5.03%-4.69%-10.83%
20217.92%-2.00%-0.47%2.17%-2.92%5.61%-2.50%4.10%-4.65%0.31%-6.10%1.03%1.54%
2020-3.25%-7.27%-7.14%14.54%8.99%0.39%1.26%-0.56%-3.50%-0.14%12.99%9.77%25.66%
201911.64%4.32%0.67%-5.43%-7.25%10.56%-1.10%-5.54%-5.25%7.72%8.44%0.92%18.65%
201810.54%-1.84%-3.81%-2.32%7.03%6.32%5.03%4.47%-0.96%-13.80%3.42%-11.19%-0.19%
20175.00%7.07%-2.95%1.92%-2.99%9.77%1.97%4.70%2.40%-6.63%-0.99%2.17%22.28%
2016-23.73%-4.33%3.85%2.72%3.51%-9.12%11.38%-2.52%4.53%-10.92%9.02%-4.46%-22.90%
20155.52%3.49%0.58%-3.97%9.17%1.15%1.93%-9.93%-14.45%9.41%1.94%-0.30%1.72%
201413.25%7.60%-7.80%-4.66%-0.76%11.56%-1.65%11.14%-3.18%7.94%1.74%-1.10%36.34%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PBE is 11, meaning it’s performing worse than 89% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PBE is 1111
Overall Rank
The Sharpe Ratio Rank of PBE is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of PBE is 1111
Sortino Ratio Rank
The Omega Ratio Rank of PBE is 1111
Omega Ratio Rank
The Calmar Ratio Rank of PBE is 1111
Calmar Ratio Rank
The Martin Ratio Rank of PBE is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Invesco Dynamic Biotechnology & Genome ETF Sharpe ratios as of May 17, 2025 (values are recalculated daily):

  • 1-Year: -0.19
  • 5-Year: 0.07
  • 10-Year: 0.04
  • All Time: 0.30

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Invesco Dynamic Biotechnology & Genome ETF compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Invesco Dynamic Biotechnology & Genome ETF provided a 0.07% dividend yield over the last twelve months, with an annual payout of $0.04 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%$0.00$0.10$0.20$0.30$0.40$0.50$0.6020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.04$0.03$0.01$0.00$0.00$0.03$0.00$0.00$0.27$0.15$0.57$0.28

Dividend yield

0.07%0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%

Monthly Dividends

The table displays the monthly dividend distributions for Invesco Dynamic Biotechnology & Genome ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.03$0.00$0.00$0.03
2024$0.00$0.00$0.02$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2023$0.00$0.00$0.00$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.01
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.06$0.00$0.00$0.22$0.00$0.00$0.00$0.00$0.00$0.00$0.27
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.00$0.00$0.12$0.15
2015$0.00$0.00$0.00$0.00$0.00$0.12$0.00$0.00$0.14$0.00$0.00$0.31$0.57
2014$0.23$0.00$0.00$0.04$0.00$0.00$0.00$0.28

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Invesco Dynamic Biotechnology & Genome ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Invesco Dynamic Biotechnology & Genome ETF was 45.69%, occurring on Mar 9, 2009. Recovery took 407 trading sessions.

The current Invesco Dynamic Biotechnology & Genome ETF drawdown is 25.56%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.69%Oct 16, 2007351Mar 9, 2009407Oct 18, 2010758
-44.56%Jul 20, 2015238Jun 27, 20161022Jul 20, 20201260
-37.84%Feb 9, 2021340Jun 14, 2022
-26.36%May 13, 201160Aug 8, 2011227Jul 2, 2012287
-21.12%Feb 28, 200697Jul 17, 2006192Apr 23, 2007289

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...